BLOG | Alphawatch

top of page

June 2025 Riffin' on Real Estate

June 2025 Riffin' on Real Estate

June 2025 Riffin' on Real Estate

Jonathan Poyer

4 days ago1 min read

Looking At Palantir Technologies (PLTR) and its +74.24% Stock Rise into June

Looking At Palantir Technologies (PLTR) and its +74.24% Stock Rise into June

Looking At Palantir Technologies (PLTR) and its +74.24% Stock Rise into June

Jonathan Poyer

Jun 62 min read

Sanofi with a $9.1B Acquisition of Blueprint & Cancer Conference Shows Successes for Diagnostics, Therapy, and Treatments

Sanofi with a $9.1B Acquisition of Blueprint & Cancer Conference Shows Successes for Diagnostics, Therapy, and Treatments

Sanofi with a $9.1B Acquisition of Blueprint & Cancer Conference Shows Successes for Diagnostics, Therapy, and Treatments

Biotech & Healthcare

Jonathan Poyer

Jun 42 min read

The Doctor is IN | May 2025

The Doctor is IN | May 2025

The Doctor is IN | May 2025

Dr. is IN Monthly Call Recordings

Jonathan Poyer

May 161 min read

Where Are the Biotech IPOs and Deals?

Where Are the Biotech IPOs and Deals?

Where Are the Biotech IPOs and Deals?

Biotech & Healthcare

Jonathan Poyer

May 161 min read

Commerical Aerospace Ideas and Why It is an Interesting Mid- and Long-Term Investing Opportunity

Commerical Aerospace Ideas and Why It is an Interesting Mid- and Long-Term Investing Opportunity

Commerical Aerospace Ideas and Why It is an Interesting Mid- and Long-Term Investing Opportunity

Jonathan Poyer

May 124 min read

Novartis to Acquire Regulus Therapeutics for $1.7B

Novartis to Acquire Regulus Therapeutics for $1.7B

Novartis to Acquire Regulus Therapeutics for $1.7B

Biotech & Healthcare

Jonathan Poyer

Apr 301 min read

Following the Trend Following Trend...

Following the Trend Following Trend...

Following the Trend Following Trend...

Jonathan Poyer

Apr 252 min read

The Doctor is IN | April 2025

The Doctor is IN | April 2025

The Doctor is IN | April 2025

Jonathan Poyer

Apr 221 min read

Merck's Announcement of Successful Phase 3 Trial of Subcutaneous Keytruda Progresses Towards FDA Submission

Merck's Announcement of Successful Phase 3 Trial of Subcutaneous Keytruda Progresses Towards FDA Submission

Merck's Announcement of Successful Phase 3 Trial of Subcutaneous Keytruda Progresses Towards FDA Submission

Biotech & Healthcare

Jonathan Poyer

Mar 312 min read

AbbVie and the Influence of AI on Research

AbbVie and the Influence of AI on Research

AbbVie and the Influence of AI on Research

Biotech & Healthcare

Jonathan Poyer

Mar 241 min read

March Shows Some Life for Biotech M&A With Over $1.7B in Deals.

March Shows Some Life for Biotech M&A With Over $1.7B in Deals.

March Shows Some Life for Biotech M&A With Over $1.7B in Deals.

Biotech & Healthcare

Jonathan Poyer

Mar 211 min read

The Doctor is IN | March 2025

The Doctor is IN | March 2025

The Doctor is IN | March 2025

Dr. is IN Monthly Call Recordings

Jonathan Poyer

Mar 211 min read

Patient Death Associated with Sarepta Drug - Stock Plummets

Patient Death Associated with Sarepta Drug - Stock Plummets

Patient Death Associated with Sarepta Drug - Stock Plummets

Biotech & Healthcare

Jonathan Poyer

Mar 211 min read

March 2025 Riffin' on Real Estate

March 2025 Riffin' on Real Estate

March 2025 Riffin' on Real Estate

Riffin' on Real Estate Recordings

Jonathan Poyer

Mar 131 min read

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Medicare Advantage Rates Set to Increase. CVS Among Others Benefitting

Biotech & Healthcare

Jonathan Poyer

Mar 62 min read

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

2 MedTech IPOs as KMTS and ADVB List to the NASDAQ. JAZZ Announces Acquisition of Chimerix for $935M

Biotech & Healthcare

Jonathan Poyer

Mar 61 min read

Meet the Manager: Anna Damato, PhD

Meet the Manager: Anna Damato, PhD

Meet the Manager: Anna Damato, PhD

Biotech & Healthcare

Jonathan Poyer

Mar 64 min read

Tariffs and Their Potential Impact on Medical Devices

Tariffs and Their Potential Impact on Medical Devices

Tariffs and Their Potential Impact on Medical Devices

Biotech & Healthcare

Jonathan Poyer

Mar 62 min read

MedTech M&A Outpacing Biotech So Far in 2025. Novartis Acquires Anthos and Cosette Acquires Mayne

MedTech M&A Outpacing Biotech So Far in 2025. Novartis Acquires Anthos and Cosette Acquires Mayne

MedTech M&A Outpacing Biotech So Far in 2025. Novartis Acquires Anthos and Cosette Acquires Mayne

Biotech & Healthcare

Jonathan Poyer

Feb 271 min read

bottom of page